Work

2942 Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adults With Nonalcoholic Steatohepatitis (NASH): AURORA Phase 3 Study Design

Year: 2019

Type: article

Study design: Study Protocol

Source: The American Journal of Gastroenterology

DOI: 10.14309/01.ajg.0000601300.34038.4b

Authors: Quentin M. Anstee, Brent A. Neuschwander-Tetri, Vincent Wai-Sun Wong, Manal F. Abdelmalek, Zobair Younossi, Naim Alkhouri, Jiacheng Yuan, Maria Lucia Pecoraro, Star Seyedkazemi, Laurent Fischer, Pierre Bedossa, Zachary Goodman, Arun Sanyal

Institutions: Newcastle University, Saint Louis University, Chinese University of Hong Kong, Duke University, Inova Health System, Texas Liver Institute, Hôpital Beaujon, Virginia Commonwealth University

Language: English

Topic: Liver Disease Diagnosis and Treatment

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2979973273

FWCI: 0.384

Cites:

Cited by: 2

Related to: 10